Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Biomarkers for Alzheimer’s disease and Parkinson’s disease.

BIOMARKAPD

Neurodegenerative disorders, represented mostly by Alzheimer's disease (AD) and Parkinson's disease (PD), are characterised by progressive neuronal impairment and death. In spite of the brain's known capacity for regeneration, lost neurons generally cannot be replaced. Therefore, drugs aimed at inhibiting neurodegenerative processes are likely to...

Funding Programme
Start Date
End Date
Total Funding
€ 449 066

Co-designing a Home with Dementia

HOMEDEM

The Doctoral Network “Co-designing a Home with Dementia” (HOMEDEM) is a Marie-Skłodowska-Curie Actions' Innovative Training Network that will provide high-level training in design and dementia caregiving, to high achieving, early-stage researchers. HOMEDEM focuses on the recent move across Europe towards supporting people with dementia (PwD) living...

Funding Programme
Start Date
End Date
Total Funding
€ 2 122 747
European Countries Involved

Cognitive Aging: From Educational Opportunities to Individual Risk Profiles

CRISP

Cognitive impairment and dementia have dramatic individual and social consequences, and create high economic costs for societies. In order to delay cognitive aging of future generations as long as possible, we need evidence about which contextual factors are most supportive for individuals to reach highest cognitive levels relative to their...

Funding Programme
Start Date
End Date
Total Funding
€ 1 148 290
European Countries Involved

COMORBIDITY MECHANISMS UTILIZED IN HEALTHCARE

COMMUTE

The COVID pandemic can be seen as an experiment done with the entirety of humankind (as almost everybody has been or will get infected with SARS-CoV-2). It will therefore have the best coverage over the widest variation possible and is therefore ideally suited to study the effects of infections with SARS-CoV-2 on large quantities of heterogeneous...

Funding Programme
Start Date
End Date
Total Funding
€ 7 280 986

Designing for People with Dementia: designing for mindful self-empowerment and social engagement

MinD

This project aims to help people with dementia engage in social contexts to improve psychosocial wellbeing. People who are affected by Alzheimer’s disease or other dementias often face cognitive, behavioural and psychosocial difficulties, including impairment and degeneration of memory and of perceptions of identity. In a social context, this can...

Funding Programme
Start Date
End Date
Total Funding
€ 549 000
European Countries Involved

Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes

DORIAN GRAY

DORIAN GRAY project investigates the link between cardiovascular disease (CVD) and Mild Cognitive Impairment (MCI) in the ageing population. Its goal is to uncover underlying mechanisms to promote healthy, independent, and active living while reducing disease burden. Aligned with EU-Horizon Europe’s Strategic Plan on NCDs prevention, the project...

Funding Programme
Start Date
End Date
Total Funding
€ 10 921 114

Diagnostic Enhancement of Confidence by an International Distributed Environment

DECIDE

DECIDE (Diagnostic Enhancement of Confidence by an International Distributed Environment), aims at creating a e-Infrastructure to enhance the diagnostic confidence in chronic brain diseases such as Alzheimer and dementia. Proper management of these neurodegenerative diseases are thought to be very important in terms of health-economical point of...

Funding Programme
Start Date
End Date
Total Funding
€ 3 004 531
European Countries Involved

Dissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Protect and Maintain a Healthy Brain

EXPOSIGNALZ

Human populations are impregnated by various types of chemical pollutants reported as hazardous waste present in the environment. Certain pollutants have adverse effects on brain, but the underlying mechanisms and time-window exposures are still unknown, as well as their contribution on dementia, the 7th leading cause of death. EXPOSIGNALZ project...

Funding Programme
Start Date
End Date
Total Funding
€ 930 987 982
European Countries Involved

eBRAIN-Health - Actionable Multilevel Health Data

eBRAIN-Health

The Project eBrain-Health will deliver a distributed research platform for modeling and simulating complex neurobiological phenomena of human brain function and dysfunction in a data protection compliant environment. It will provide thousands of multilevel virtual brains from patients and healthy human controls for research and innovation. Brain...

Funding Programme
Start Date
End Date
Total Funding
€ 12 436 805

Efficiently networking European neurodegeneration research

NEURONET

IMI’s growing neurodegenerative disorders (ND) portfolio is to get a new, dynamic platform – NEURONET – that will make it easier for the many projects to exploit synergies and connect the resources and needs of the different projects. NEURONET aims to be a key enabler and mediator across the portfolio, assisting in identifying gaps, multiplying...

Funding Programme
Start Date
End Date
Total Funding
€ 2 353 125
European Countries Involved

EURO-FINGERS multimodal precision prevention toolbox for dementia in Alzheimer’s disease

EU-FINGERS

Prevention of Alzheimer’s disease (AD) and dementia is a global public health priority. EURO-FINGERS builds upon the successful experiences of two multimodal prevention trials: the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) and the JPND-funded MIND-AD. The FINGER intervention trial showed that a...

Funding Programme
Start Date
End Date
Total Funding
€ 1 800 000
European Countries Involved

European Medical Information Framework

EMIF

In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts. However, data sources are typically fragmented and contain information...

Funding Programme
Start Date
End Date
Total Funding
€ 53 642 677
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).